Comments on current antibiotic therapy.
D000583:Amikacin / Q000627:therapeutic use; D000617:Aminoglycosides / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D002981:Clindamycin / Q000627:therapeutic use; D004338:Drug Combinations; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000627:therapeutic use; D009254:Nafcillin / Q000627:therapeutic use; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000494:pharmacology / Q000627:therapeutic use; D013514:Surgical Procedures, Operative; D013982:Ticarcillin / Q000627:therapeutic use; D014031:Tobramycin / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005839:Gentamicins; D002981:Clindamycin; D009254:Nafcillin; D000583:Amikacin; D014295:Trimethoprim; D013982:Ticarcillin; D008911:Minocycline; D013420:Sulfamethoxazole; D014031:Tobramycin